Cost–Utility Analysis of Selective Internal Radiation Therapy with Y-90 Resin Microspheres in Hepatocellular Carcinoma
Open Access
- 23 November 2020
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 17 (9) , 1055-1068
Abstract
Background: The study assessed the cost-utility of selective internal radiation therapy (SIRT) with Y-90 resin microspheres versus sorafenib in UK patients with unresectable hepatocellular carcinom... Lay abstract Hepatocellular carcinoma is a complex disease, where in advanced stages there are limited treatment options. Among patients who are not eligible for liver transplant, removal of the tu...Keywords
Funding Information
- Sirtex Medical Ltd
This publication has 32 references indexed in Scilit:
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2018
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Insights Into the Hepatocellular Carcinoma Patient Journey: Results of the First Global Quality of Life SurveyFuture Oncology, 2018
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialThe Lancet Oncology, 2017
- Sorafenib in Patients with Hepatocellular Carcinoma—Results of the Observational INSIGHT StudyClinical Cancer Research, 2017
- Sorafenib for the Treatment of Advanced Hepatocellular Cancer – a UK AuditClinical Oncology, 2017
- Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON studyJournal of Hepatology, 2016
- The societal burden of chronic liver diseases: results from the COME studyBMJ Open Gastroenterology, 2015
- Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinomaWorld Journal of Gastroenterology, 2012
- The prevalence of psychological distress by cancer sitePsycho-Oncology, 2001